Oxaliplatin-related neurotoxicity: How and why?
Top Cited Papers
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 59 (2) , 159-168
- https://doi.org/10.1016/j.critrevonc.2006.01.001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancerAnnals of Oncology, 2005
- Randomized Multicenter Phase II Trial of Bolus Plus Infusional Fluorouracil/Leucovorin Compared With Fluorouracil/Leucovorin Plus Oxaliplatin As Third-Line Treatment of Patients With Advanced Colorectal CancerJournal of Clinical Oncology, 2004
- Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium InfusionsClinical Cancer Research, 2004
- XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Therapeutic Strategies for Metastatic Colorectal Cancer: Simultaneous, Sequential, or Specific?Journal of Clinical Oncology, 2003
- Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III TrialJournal of Clinical Oncology, 2003
- High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)European Journal Of Cancer, 2001
- Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)European Journal Of Cancer, 1999
- A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinomaAnti-Cancer Drugs, 1997